FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

19338005: 2 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    32597014 Two en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442102012 2 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442103019 2 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    33051000077117 deux fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    deux Is a General adjectival modifier false Inferred relationship Some
    deux Is a nombre false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely nitrofural 2 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has concentration strength numerator value False deux Inferred relationship Some 1
    Product containing precisely esterified estrogen 625 microgram and methyltestosterone 1.25 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Nicotine (as nicotine polacrilex) 2 mg oral gum chewing gum Has presentation strength numerator value False deux Inferred relationship Some 1
    Product containing precisely nicotine (as nicotine polacrilex) 2 milligram/1 each conventional release oromucosal lozenge (clinical drug) Has presentation strength numerator value False deux Inferred relationship Some 1
    Product containing precisely paracetamol 24 milligram/1 milliliter and promethazine hydrochloride 300 microgram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Mucin 63 mg and xylitol 39 mg oromucosal lozenge Count of base of active ingredient False deux Inferred relationship Some
    Theophylline 2 mg/mL oral solution Has concentration strength numerator value False deux Inferred relationship Some 1
    Ipratropium bromide 167 microgram/mL and salbutamol (as salbutamol sulfate) 833 microgram/mL solution for inhalation Count of base of active ingredient False deux Inferred relationship Some
    Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and etidocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Frangula 80 microgram/mg and Sterculia gum 620 microgram/mg oral granules Count of base of active ingredient False deux Inferred relationship Some
    Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely cefepime (as cefepime hydrochloride) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False deux Inferred relationship Some 1
    Product containing precisely calcium carbonate 1.5 gram and colecalciferol 10 microgram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Ampicillin (as ampicillin sodium) 1 g and sulbactam (as sulbactam sodium) 500 mg powder for solution for injection vial Count of base of active ingredient False deux Inferred relationship Some
    Estrone 2 mg/mL suspension for injection Has concentration strength numerator value False deux Inferred relationship Some 1
    Nafcillin (as nafcillin sodium) 2 g powder for solution for injection vial Has presentation strength numerator value False deux Inferred relationship Some 1
    Product containing precisely ampicillin (as ampicillin sodium) 2 gram and sulbactam (as sulbactam sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Aspirin 500 mg and glycine 133 mg orodispersible tablet Count of base of active ingredient False deux Inferred relationship Some
    Alprazolam 2 mg orodispersible tablet Has presentation strength numerator value False deux Inferred relationship Some 1
    Pituitary follicle stimulating hormone 75 unit and pituitary luteinizing hormone 75 unit powder for solution for injection vial Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely oxacillin (as oxacillin sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False deux Inferred relationship Some 1
    Product containing precisely cefotetan (as cefotetan disodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False deux Inferred relationship Some 1
    Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet Count of base of active ingredient False deux Inferred relationship Some
    Calcium electrolyte 1.25 g and colecalciferol 10 microgram chewable tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely omeprazole 40 milligram and sodium bicarbonate 1.68 gram/1 sachet powder for conventional release oral suspension (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Diazepam 2 mg/mL rectal solution Has concentration strength numerator value False deux Inferred relationship Some 1
    Product containing precisely omeprazole 20 milligram and sodium bicarbonate 1.68 gram/1 sachet powder for conventional release oral suspension (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Sodium benzoate 100 mg/mL and sodium phenylacetate 100 mg/mL solution for injection Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely insulin lispro 25 unit/1 milliliter and insulin lispro protamine 75 unit/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely insulin lispro 50 unit/1 milliliter and insulin lispro protamine 50 unit/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely porcine isophane insulin 70 unit/1 milliliter and porcine regular insulin 30 unit/1 milliliter conventional release suspension for injection (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely human isophane insulin 70 unit/1 milliliter and recombinant human regular insulin 30 unit/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely human isophane insulin 60 unit/1 milliliter and recombinant human regular insulin 40 unit/1 milliliter conventional release suspension for injection (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely human isophane insulin 90 unit/1 milliliter and recombinant human regular insulin 10 unit/1 milliliter conventional release suspension for injection (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely human isophane insulin 85 unit/1 milliliter and recombinant human regular insulin 15 unit/1 milliliter conventional release suspension for injection (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely human isophane insulin 80 unit/1 milliliter and recombinant human regular insulin 20 unit/1 milliliter conventional release suspension for injection (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely human isophane insulin 75 unit/1 milliliter and recombinant human regular insulin 25 unit/1 milliliter conventional release suspension for injection (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram and naproxen 500 milligram/1 each gastro-resistant oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Dextromethorphan hydrobromide 3 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely caffeine 650 microgram/1 milliliter and paracetamol 5 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Dexamethasone 1 mg/mL and hypromellose 5 mg/mL eye solution Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 10.4 microgram/1 hour prolonged-release transdermal patch (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Bromazine hydrochloride 2.5 mg/mL and codeine phosphate 2 mg/mL oral solution Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely guanfacine (as guanfacine hydrochloride) 2 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength numerator value False deux Inferred relationship Some 1
    Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution Count of base of active ingredient False deux Inferred relationship Some
    Brompheniramine maleate 400 microgram/mL and codeine phosphate 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution Has concentration strength numerator value False deux Inferred relationship Some 1
    Product containing precisely citalopram (as citalopram hydrobromide) 2 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False deux Inferred relationship Some 1
    Product containing precisely ibuprofen 20 milligram/1 milliliter and pseudoephedrine hydrochloride 3 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Estradiol 1.88 microgram/hour and levonorgestrel 625 nanogram/hour prolonged-release transdermal patch Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely guaifenesin 1.2 gram and pseudoephedrine hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely methylprednisolone 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False deux Inferred relationship Some 1
    Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely ciprofloxacin 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug) Has concentration strength numerator value False deux Inferred relationship Some 1
    Product containing precisely ciprofloxacin 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely guaifenesin 600 milligram and pseudoephedrine hydrochloride 60 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram and naproxen (as naproxen sodium) 375 milligram/1 each gastro-resistant oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely bupivacaine hydrochloride 5 milligram/1 milliliter and epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely codeine phosphate 1 milligram/1 milliliter and kaolin 300 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely fenoterol 500 microgram and ipratropium 1.25 milligram/1 actuation conventional release solution for inhalation (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch Count of base of active ingredient False deux Inferred relationship Some
    Buprenorphine (as buprenorphine hydrochloride) 8 mg and naloxone hydrochloride 2 mg sublingual tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely diprophylline 6.67 milligram/1 milliliter and guaifenesin 6.67 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 7.5 mg/mL solution for injection Count of base of active ingredient False deux Inferred relationship Some
    Acetic acid 9 mg/g and oxyquinoline (as oxyquinoline sulfate) 250 microgram/g vaginal gel Count of base of active ingredient False deux Inferred relationship Some
    Calcium carbonate 6.25 mg/mL and colecalciferol 2.2 unit/mL oral solution Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and calcipotriol 50 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Diphenhydramine hydrochloride 20 mg/mL and zinc acetate 1 mg/mL cutaneous cream Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter and sodium nitrite 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Estradiol 2.08 microgram/hour and norethisterone acetate 5.83 microgram/hour prolonged-release transdermal patch Count of base of active ingredient False deux Inferred relationship Some
    Carbinoxamine maleate 1 mg/mL and pseudoephedrine hydrochloride 15 mg/mL oral solution Count of base of active ingredient False deux Inferred relationship Some
    Thioridazine 2 mg/mL oral solution Has concentration strength numerator value False deux Inferred relationship Some 1
    Codeine phosphate 2 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely fluorescein sodium stain 2.5 milligram/1 milliliter and proxymetacaine hydrochloride 5 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Cocaine (as cocaine hydrochloride) 20 mg/mL and homatropine hydrobromide 20 mg/mL eye solution Count of base of active ingredient False deux Inferred relationship Some
    Buprenorphine 2 mg and naloxone hydrochloride 500 microgram sublingual tablet Has presentation strength numerator value False deux Inferred relationship Some 2
    Buprenorphine 2 mg and naloxone hydrochloride 500 microgram sublingual tablet Count of base of active ingredient False deux Inferred relationship Some
    Hydrocortisone 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL ear solution Count of base of active ingredient False deux Inferred relationship Some
    Memantine hydrochloride 2 mg/mL oral solution Has concentration strength numerator value False deux Inferred relationship Some 1
    Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution Count of base of active ingredient False deux Inferred relationship Some
    Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Miconazole nitrate 2.5 mg/g and zinc oxide 150 mg/g cutaneous ointment Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely fluorometholone acetate 1 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Clindamycin phosphate 12 mg/g and tretinoin 250 microgram/g cutaneous gel Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely benzoyl peroxide 25 milligram/1 gram and clindamycin phosphate 12 milligram/1 gram conventional release cutaneous gel (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Lidocaine hydrochloride 2 mg/mL solution for injection Has concentration strength numerator value False deux Inferred relationship Some 1
    Clonazepam 2 mg orodispersible tablet Has presentation strength numerator value False deux Inferred relationship Some 1
    Product containing precisely choline 200 milligram/1 milliliter and glycerol 126 milligram/1 milliliter conventional release ear solution (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Hydrocortisone acetate 2.75 mg/g and lidocaine hydrochloride 50 mg/g cutaneous ointment Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely gemcitabine (as gemcitabine hydrochloride) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False deux Inferred relationship Some 1
    Glucose 40 mg/mL and sodium chloride 1.8 mg/mL solution for injection Count of base of active ingredient False deux Inferred relationship Some
    Glucose 50 mg/mL and sodium chloride 1.8 mg/mL solution for injection Count of base of active ingredient False deux Inferred relationship Some
    Adrenaline 10 microgram/mL and lidocaine hydrochloride 10 mg/mL solution for injection Count of base of active ingredient False deux Inferred relationship Some
    Hydrocodone bitartrate 500 microgram/mL and paracetamol 21.7 mg/mL oral solution Count of base of active ingredient False deux Inferred relationship Some
    Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely hydrocodone bitartrate 333 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Adrenaline (as adrenaline acid tartrate) 1 mg/mL and guanethidine 5 mg/mL eye solution Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely hydrocodone bitartrate 500 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False deux Inferred relationship Some

    Start Previous Page 21 of 24 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start